• No se han encontrado resultados

TítuloDiagnosis, clinical course, and 1 year outcome in patients hospitalized for heart failure with preserved ejection fraction (from the Polish Cohort of the European Society of Cardiology Heart Failure Long Term Registry)

N/A
N/A
Protected

Academic year: 2020

Share "TítuloDiagnosis, clinical course, and 1 year outcome in patients hospitalized for heart failure with preserved ejection fraction (from the Polish Cohort of the European Society of Cardiology Heart Failure Long Term Registry)"

Copied!
13
0
0

Texto completo

Loading

Figure

Figure 1. Flow chart of patient selection for the current analysis. FU = follow-up; pts = patients
Table 1. Baseline clinical characteristics and previous pharmacotherapy in patients with heart failure with preserved ejection  fraction (HF-PEF) and in patients with heart failure with reduced ejection fraction (HF-REF)
Table 2. Clinical and laboratory status at hospital admission, and echocardiographic findings during index hospitalization in patients  with heart failure with preserved ejection fraction PEF) and in patients with heart failure with reduced ejection fracti
Table 3. Management during index hospitalization, clinical status, laboratory findings and pharmacotherapy at discharge, as well as  in-hospital and long-term outcomes of patients with heart failure with preserved ejection fraction (HF-PEF) and of patients
+3

Referencias

Documento similar

In controlled clinical trials the incidence of reports of heart failure with pioglitazone treatment was the same as in placebo, metformin and sulphonylurea treatment groups, but

The incidence and prevalence of these diseases are increasingly globally, and although more research is needed to elucidate its role in pathologies such as atrial

Evaluation of HFpEF in mouse models requires assessing three major key features defining this complex syndrome: the presence of a preserved left ventricular ejection fraction

Robertson, "Heart rate spectral analysis as an indicator of autonomie function in patients with autonomie failure", Annual International Conference of the IEEE Engineering

† Joint position statement of the European Academy of Paediatric (EAP), the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN), the European

This study is part of a bigger and ambitious research project with the general aim to achieve a standardized and unique self-reported scale in Spanish-speaking population to

AAV9-CnAβ1 decreases the expression of genes associated with heart failure and fibrosis in the remote myocardium post MI – AAV9-CnAβ1 administration at a dose of 3.5e10 VP,

van Bilsen et al., “Long-term severe diabetes only leads to mild cardiac diastolic dysfunction in Zucker diabetic fatty rats,” European Journal of Heart Failure, vol.. Ares-Carrasco